The Task-force in Europe for Drug Development for the Young (TEDDY) is a Network of Excellence (NoE)  funded in 2005 as a consortium responding to a call published by the European Commission and aimed at “structuring efforts devoted to the development of medicines tailored for children”.

Between 2005-2010, the FP6 TEDDY project (LSHB-CT-2005-005216) played a critical role in the start-up of paediatric activities in Europe, in parallel with the introduction of the new European Paediatric Regulation.

Since 2010 TEDDY has revised its organisation and gathered research centres and groups willing to be engaged in developing clinical research. Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from 15 countries aimed at facilitating the performance of good quality paediatric studies and research.

TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.

Latest News

2901, 2018

TEDDY supports the Rare Disease Day 2018

TEDDY Network is pleased to support The Rare Disease Day 2018, that will take place on the last day of February 28th, to raise awareness of rare diseases and their impact on patients'

1701, 2018

ERN-LUNG builds a new infrastructure for patient data management

In October 2017, the European Reference Network for rare diseases of the respiratory system (ERN-LUNG) won the competition for a grant from the European Union to establish registries of patient data and make